Atlı Neslihan, Kaplan Serin Emine
Sanlıurfa Training and Research Hospital, Pediatric Emergency Clinic, Sanlıurfa, 63250, Turkey.
Internal Medical Nursing Department, Nursing Faculty, Mersin University, Mersin, Turkey.
J Tissue Viability. 2024 Nov;33(4):985-991. doi: 10.1016/j.jtv.2024.08.006. Epub 2024 Sep 1.
To prevent incontinence-associated dermatitis (IAD) and manage the treatment, the cause of IAD must be determined correctly and distinguished from other skin problems. IAD can be prevented with professional care.
This systematic review aims to systematically examine the methods used in the prevention and treatment of urinary incontinence-associated dermatitis.
The PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) criteria were taken as the basis for creating the systematic review protocol and writing the article. In this systematic review, the scans are combinations of words and word groups determined by the MeSH (Medical Subject Headings) terms "incontinence", "incontinence-associated dermatitis", "prevention of urinary incontinence", "treatment of urinary incontinence" and "randomized controlled". Studies conducted in the last eight years were examined in the PubMed, Cochrane Library, Web of Science, and Scopus databases between January and March 2024. Studies were selected by determining inclusion and exclusion criteria according to the PICOS method and these studies included in the review were evaluated according to the Joanna Briggs Institute (JBI) critical evaluation lists according to their types.
Five randomized controlled trials with a total of 644 participants were included in this systematic review. In all five studies included in the review, it was determined that pharmacological and non-pharmacological methods significantly reduced dermatitis associated with urinary incontinence.
In the reviewed studies, it was observed that pharmacological and non-pharmacological methods had a positive effect on dermatitis in individuals with IAD. It is recommended to conduct more studies of high methodological quality, using larger sample groups, with different interventions and randomization and blinding methods, and examining the effectiveness of pharmacological and non-pharmacological methods in individuals with urinary incontinence-associated dermatitis.
为预防失禁相关性皮炎（IAD）并进行治疗管理，必须正确确定IAD的病因并与其他皮肤问题相区分。通过专业护理可预防IAD。
本系统评价旨在系统地研究预防和治疗尿失禁相关性皮炎所采用的方法。
以PRISMA-P（系统评价与Meta分析方案的首选报告项目）标准为基础制定系统评价方案并撰写本文。在本系统评价中，检索词是由医学主题词（MeSH）术语“失禁”、“失禁相关性皮炎”、“尿失禁的预防”、“尿失禁的治疗”和“随机对照”确定的单词和词组组合。于2024年1月至3月在PubMed、Cochrane图书馆、科学网和Scopus数据库中检索过去八年开展的研究。根据PICOS方法确定纳入和排除标准来选择研究，并根据乔安娜·布里格斯研究所（JBI）的批判性评价清单按类型对纳入本评价的这些研究进行评估。
本系统评价纳入了五项随机对照试验，共有644名参与者。在纳入评价的所有五项研究中，均确定药物和非药物方法可显著降低与尿失禁相关的皮炎。
在所审查的研究中，观察到药物和非药物方法对IAD患者的皮炎有积极影响。建议开展更多方法学质量高的研究，使用更大的样本组，采用不同的干预措施以及随机化和盲法，并研究药物和非药物方法对尿失禁相关性皮炎患者的有效性。
